- Home
- CDNA vs NIE Comparison
CDNA vs NIE Comparison
Compare CDNA & NIE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- NIE
- Stock Information
- Founded
- CDNA 1998
- NIE 2007
- Country
- CDNA United States
- NIE United States
- Employees
- CDNA N/A
- NIE N/A
- Industry
- CDNA Medical Specialities
- NIE Investment Managers
- Sector
- CDNA Health Care
- NIE Finance
- Exchange
- CDNA Nasdaq
- NIE Nasdaq
- Market Cap
- CDNA 712.2M
- NIE 676.4M
- IPO Year
- CDNA 2014
- NIE N/A
- Fundamental
- Price
- CDNA $13.82
- NIE $24.90
- Analyst Decision
- CDNA Buy
- NIE
- Analyst Count
- CDNA 7
- NIE 0
- Target Price
- CDNA $27.67
- NIE N/A
- AVG Volume (30 Days)
- CDNA 1.5M
- NIE 70.5K
- Earning Date
- CDNA 11-03-2025
- NIE 01-01-0001
- Dividend Yield
- CDNA N/A
- NIE 9.04%
- EPS Growth
- CDNA N/A
- NIE N/A
- EPS
- CDNA 1.00
- NIE N/A
- Revenue
- CDNA $340,826,000.00
- NIE N/A
- Revenue This Year
- CDNA $13.02
- NIE N/A
- Revenue Next Year
- CDNA $12.85
- NIE N/A
- P/E Ratio
- CDNA $13.85
- NIE N/A
- Revenue Growth
- CDNA 14.72
- NIE N/A
- 52 Week Low
- CDNA $10.96
- NIE $18.61
- 52 Week High
- CDNA $32.97
- NIE $22.47
- Technical
- Relative Strength Index (RSI)
- CDNA 54.96
- NIE 68.24
- Support Level
- CDNA $12.37
- NIE $24.53
- Resistance Level
- CDNA $14.20
- NIE $24.92
- Average True Range (ATR)
- CDNA 0.73
- NIE 0.21
- MACD
- CDNA 0.27
- NIE 0.03
- Stochastic Oscillator
- CDNA 87.02
- NIE 88.78
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About NIE Virtus Equity & Convertible Income Fund of Beneficial Interest
Virtus AllianzGI Equity & Convertible Income Fund is a diversified, closed-end management investment company. The investment objective is to seek total return comprised of capital appreciation, current income, and gains. The fund pursues its objective by investing in a diversified portfolio of equity securities and income-producing convertible securities. Its portfolio of investments comprises different sector investments, such as aerospace and defense, banks, IT services, software, and others.